A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
about
A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase.Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator.Two step synthesis of a non-symmetric acetylcholinesterase reactivator.Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.Bisquaternary oximes as reactivators of tabun-inhibited human brain cholinesterases: an in vitro study.Combined approach to demonstrate acetylcholinesterase activity changes in the rat brain following tabun intoxication and its treatment.A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase.
P2860
Q42835520-319330EF-ED5F-4F23-8132-9548B09B14C8Q43146171-C0E75B8E-C858-4FEC-880D-0689184BB408Q43271990-BDE02BBA-EABA-434B-A1D1-5AEDB0BE2BB8Q46831546-AAE70471-F85E-4996-94D4-6829DED58659Q46932459-367A1D3C-A543-4230-8EF5-ED1795D15551Q46932491-CF040195-105E-462A-A6DE-BCC02BB29754Q46970961-67586013-D517-415B-8CFB-067D0B3E2899Q48132308-CEE1F1CB-342A-44C5-BDCD-6595743FDEABQ48944326-3E1362BA-3E85-487A-8FE8-F68D9BEB16DEQ50291735-62E6186F-47AA-4A31-8184-6D316884F40D
P2860
A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@en
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@nl
type
label
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@en
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@nl
prefLabel
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@en
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@nl
P2093
P2860
P1476
A comparison of the efficacy o ...... inst tabun by in vivo methods.
@en
P2093
Jiri Cabal
Jiri Kassa
Kamil Kuca
Martin Paar
P2860
P304
P356
10.1080/15287390600631730
P577
2006-10-01T00:00:00Z